marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Larimar Therapeutics Balance Sheet 2011-2024 | LRMR
Annual Balance Sheet Larimar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-21.2 M | -21.4 M | -64.1 M | -43.7 M | -18.4 M | -28.7 M | -20.8 M | -28.8 M | -29.2 M | - | - | - | - |
Long Term Debt |
4.71 M | 4.8 M | 5.41 M | 24 M | 8.46 M | 15.2 M | 20 M | - | 3.45 M | - | - | - | - |
Long Term Debt Current |
837 K | 611 K | 594 K | 515 K | 386 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 6 M | 14.9 M | 15.2 M | 20 M | - | 3.45 M | - | - | - | - |
Total Current Liabilities |
9.51 M | 10.7 M | 8.85 M | 8.99 M | 12.2 M | 13.3 M | 7.29 M | 9.89 M | 16.5 M | 6.9 M | - | - | - |
Total Liabilities |
14.2 M | 15.5 M | 14.3 M | 15 M | 27.1 M | 28.5 M | 27.3 M | 9.89 M | 20 M | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-189 M | -152 M | -116 M | -65.6 M | -396 M | -351 M | -290 M | -238 M | -180 M | - | - | - | - |
Total Assets |
95.9 M | 126 M | 78.7 M | 105 M | 80.7 M | 122 M | 106 M | 132 M | 189 M | - | - | - | - |
Cash and Cash Equivalents |
26.7 M | 26.8 M | 70.1 M | 68.1 M | 27.2 M | 49.3 M | 40.8 M | 32.4 M | 35.6 M | 58.1 M | 35.5 M | 9.94 M | - |
Book Value |
81.7 M | 111 M | 64.4 M | 89.7 M | 53.6 M | 93.3 M | 78.2 M | 122 M | 169 M | - | - | - | - |
Total Shareholders Equity |
81.7 M | 111 M | 64.4 M | 89.7 M | -694 K | 93.3 M | 78.2 M | 122 M | 169 M | 104 M | -68.6 M | -54.7 M | - |
All numbers in USD currency
Quarterly Balance Sheet Larimar Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
4.34 M | 4.6 M | 4.52 M | 4.71 M | 4.68 M | 4.51 M | 4.66 M | 4.8 M | 4.93 M | 5.08 M | 5.24 M | 5.41 M | 5.56 M | 5.72 M | 5.86 M | 6 M | 6 M | 6 M | 6 M | 14.5 M | 16.4 M | 18.2 M | 20 M | 20 M | 20 M | 20 M | 20 M | 20 M | - | - | - | 3.18 M | 3.94 M | 4.68 M | 5.41 M | - | 6.82 M | 7.5 M | 7.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
20.6 M | 25.8 M | 17.4 M | 14.2 M | 11.2 M | 11.8 M | 12.7 M | 15.5 M | 14.4 M | 12.8 M | 14.1 M | 14.3 M | 15.9 M | 13.4 M | 14.2 M | 15 M | 15 M | 15 M | 15 M | 5.9 M | 5.9 M | 5.9 M | 27.1 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 9.89 M | 9.89 M | 9.89 M | 9.89 M | 20 M | 20 M | 20 M | 20 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 2.92 M | 2.92 M | 2.92 M | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-240 M | -225 M | -203 M | -189 M | -176 M | -166 M | -158 M | -152 M | -142 M | -134 M | -125 M | -116 M | -107 M | -90.3 M | -77.7 M | -65.6 M | -65.6 M | -65.6 M | -65.6 M | -23.1 M | -23.1 M | -23.1 M | -396 M | -351 M | -351 M | -351 M | -351 M | -290 M | -290 M | -290 M | -290 M | -238 M | -238 M | -238 M | -238 M | -180 M | -180 M | -180 M | -180 M | -105 M | -105 M | -105 M | -105 M | -68.9 M | -68.9 M | -68.9 M | - | - | - | - | - | - | - | - | - |
Total Assets |
219 M | 237 M | 248 M | 95.9 M | 104 M | 112 M | 119 M | 126 M | 133 M | 62.9 M | 71.2 M | 78.7 M | 87.9 M | 80.9 M | 93 M | 105 M | 105 M | 105 M | 105 M | 5.2 M | 5.2 M | 5.2 M | 80.7 M | 122 M | 122 M | 122 M | 122 M | 106 M | 106 M | 106 M | 106 M | 132 M | 132 M | 132 M | 132 M | 189 M | 189 M | 189 M | 189 M | 118 M | 118 M | 118 M | 118 M | 38.1 M | 38.1 M | 38.1 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
35.1 M | 32.3 M | 110 M | 26.7 M | 38.7 M | 94.3 M | 112 M | 26.8 M | 86 M | 19.7 M | 62.6 M | 70.1 M | 71.5 M | 70.6 M | 62.2 M | 68.1 M | 68.1 M | 68.1 M | 68.1 M | 1.01 M | 1.01 M | 1.01 M | 27.2 M | 49.3 M | 49.3 M | 49.3 M | 49.3 M | 40.8 M | 40.8 M | 40.8 M | 40.8 M | 32.4 M | 32.4 M | 32.4 M | 32.4 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 58.1 M | 58.1 M | 58.1 M | 58.1 M | 35.5 M | 35.5 M | 35.5 M | - | 9.94 M | - | - | - | 1.47 M | - | - | - |
Book Value |
198 M | 211 M | 231 M | 81.7 M | 92.7 M | 99.9 M | 106 M | 111 M | 119 M | 50.1 M | 57.1 M | 64.4 M | 72.1 M | 67.5 M | 78.8 M | 89.7 M | 89.7 M | 89.7 M | 89.7 M | -694 K | -694 K | -694 K | 53.6 M | 93.3 M | 93.3 M | 93.3 M | 93.3 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 122 M | 122 M | 122 M | 122 M | 169 M | 169 M | 169 M | 169 M | 104 M | 104 M | 104 M | 104 M | 35.2 M | 35.2 M | 35.2 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
198 M | 211 M | 231 M | 81.7 M | 92.7 M | 99.9 M | 106 M | 111 M | 119 M | 50.1 M | 57.1 M | 64.4 M | 72.1 M | 67.5 M | 78.8 M | 89.7 M | 89.7 M | 89.7 M | 89.7 M | -694 K | -694 K | -694 K | 53.6 M | 2.91 M | 93.3 M | 93.3 M | 93.3 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 122 M | 122 M | 122 M | 122 M | 169 M | 169 M | 169 M | 169 M | 104 M | 104 M | 104 M | 104 M | -68.6 M | -68.6 M | -68.6 M | - | -54.7 M | - | - | - | -40.9 M | - | - | - |
All numbers in USD currency